Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
Special Report by David Williams (EPSRC Center for Innovative Manufacturing in Regenerative Medicine, UK) where he and his team share their experiences in qualifying the Cell Therapy Manufacturing Facility, focusing on their approach to streamlining the qualification effort, the challenges, project delays and inefficiencies they encountered, and finally the subsequent lessons learned.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.